Glucotrack, INC. (GCTK) — 8-K Filings

All 8-K filings from Glucotrack, INC.. Browse 50 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (50)

8-K Filing — Apr 14, 2026
8-K Filing — Mar 27, 2026
Glucotrack, Inc. Files 8-K with Key Agreements and Disclosures — Dec 31, 2025 Risk: medium
Glucotrack, Inc. filed an 8-K on December 29, 2025, reporting on a material definitive agreement, unregistered sales of equity securities, and Regulation FD dis
Glucotrack, Inc. Files 8-K — Dec 29, 2025 Risk: low
Glucotrack, Inc. filed an 8-K on December 29, 2025, reporting information under Regulation FD Disclosure and Financial Statements and Exhibits. The company, for
Glucotrack, Inc. Files 8-K on Shareholder Vote Matters — Nov 7, 2025 Risk: low
Glucotrack, Inc. filed an 8-K on November 7, 2025, reporting on a submission of matters to a vote of security holders. The filing details the company's corporat
Glucotrack, Inc. Reports on Shareholder Vote Matters — Nov 6, 2025 Risk: low
Glucotrack, Inc. filed an 8-K on November 6, 2025, reporting on matters submitted to a vote of security holders as of October 31, 2025. The filing indicates a s
8-K Filing — Nov 3, 2025
Glucotrack, Inc. Files 8-K — Oct 29, 2025 Risk: low
Glucotrack, Inc. filed an 8-K on October 29, 2025, reporting information under Regulation FD Disclosure and Financial Statements and Exhibits. The company, form
Glucotrack, Inc. Files 8-K: Regulation FD & Financials — Oct 28, 2025 Risk: low
On October 28, 2025, Glucotrack, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and includes Financial Statements and Exhibits
Glucotrack, Inc. Enters Material Agreement, Reports Equity Sales — Sep 12, 2025 Risk: medium
On September 12, 2025, Glucotrack, Inc. entered into a material definitive agreement, creating a direct financial obligation. The company also reported unregist
Glucotrack, Inc. Files 8-K on Material Agreement & Equity Sales — Sep 11, 2025 Risk: medium
On September 11, 2025, Glucotrack, Inc. filed an 8-K report detailing a material definitive agreement and unregistered sales of equity securities. The filing al
Glucotrack, Inc. Files 8-K — Aug 6, 2025 Risk: low
Glucotrack, Inc. filed an 8-K on August 6, 2025, reporting information under Regulation FD Disclosure and Financial Statements and Exhibits. The company, former
Glucotrack, Inc. Files 8-K with Financials — Jul 31, 2025 Risk: low
Glucotrack, Inc. filed an 8-K on July 31, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Integ
Glucotrack Changes Auditors — Jul 24, 2025 Risk: low
Glucotrack, Inc. announced on July 18, 2025, a change in its certifying accountant. The company has dismissed its previous independent registered public account
Glucotrack, Inc. Files 8-K — Jul 8, 2025 Risk: low
Glucotrack, Inc. filed an 8-K on July 8, 2025, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific
Glucotrack, Inc. Files 8-K with Corporate Updates — Jun 25, 2025 Risk: low
Glucotrack, Inc. filed an 8-K on June 25, 2025, reporting on a Regulation FD Disclosure and Financial Statements and Exhibits. The filing details the company's
Glucotrack, Inc. Files 8-K with Corporate Updates — Jun 16, 2025 Risk: low
Glucotrack, Inc. filed an 8-K on June 16, 2025, reporting events as of June 13, 2025. The filing indicates amendments to its Articles of Incorporation or Bylaws
Glucotrack, Inc. Files 8-K — Jun 12, 2025 Risk: low
Glucotrack, Inc. filed an 8-K on June 12, 2025, reporting under Regulation FD and including financial statements and exhibits. The company, formerly known as In
Glucotrack, Inc. Files 8-K — Jun 4, 2025 Risk: low
Glucotrack, Inc. filed an 8-K on June 4, 2025, reporting under Regulation FD and including financial statements and exhibits. The company, formerly known as Int
Glucotrack, Inc. Files 8-K on Officer/Director Changes — May 23, 2025 Risk: medium
Glucotrack, Inc. filed an 8-K on May 23, 2025, reporting on the departure of directors or certain officers, the election of directors, the appointment of certai
Glucotrack, Inc. Files 8-K Report — May 20, 2025 Risk: low
On May 20, 2025, Glucotrack, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating a routine update or disclosur
Glucotrack, Inc. Files 8-K with Financials — May 13, 2025 Risk: low
Glucotrack, Inc. filed an 8-K on May 13, 2025, reporting under Regulation FD and including financial statements and exhibits. The company, formerly known as Int
8-K Filing — Apr 29, 2025
Glucotrack, Inc. Files 8-K with Financial Updates — Apr 16, 2025 Risk: low
Glucotrack, Inc. filed an 8-K on April 16, 2025, reporting on a Regulation FD Disclosure and Financial Statements and Exhibits. The filing confirms the company'
Glucotrack Faces Delisting Concerns — Apr 4, 2025 Risk: high
Glucotrack, Inc. filed an 8-K on April 4, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard. The earliest event r
Glucotrack, Inc. Files 8-K — Apr 3, 2025 Risk: low
Glucotrack, Inc. filed an 8-K on April 3, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Integ
Glucotrack, Inc. Files 8-K: Reg FD & Financials — Mar 19, 2025 Risk: low
Glucotrack, Inc. filed an 8-K on March 19, 2025, reporting on a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as I
Glucotrack Reports Unregistered Equity Sales — Mar 13, 2025 Risk: medium
Glucotrack, Inc. filed an 8-K on March 13, 2025, reporting unregistered sales of equity securities on March 11, 2025. The filing does not disclose specific deta
Glucotrack, Inc. Files 8-K — Feb 26, 2025 Risk: low
Glucotrack, Inc. filed an 8-K on February 26, 2025, to report on Regulation FD disclosures and financial statements. The filing confirms the company's name as G
Glucotrack, Inc. Files 8-K — Feb 14, 2025 Risk: low
Glucotrack, Inc. filed an 8-K on February 14, 2025, reporting on Regulation FD disclosures and financial statements. The company, formerly known as Integrity Ap
Glucotrack, Inc. Signs Material Definitive Agreement — Feb 5, 2025 Risk: medium
On February 4, 2025, Glucotrack, Inc. entered into a material definitive agreement. The filing does not disclose specific details of the agreement, the counterp
Glucotrack, Inc. Files 8-K with Corporate Updates — Feb 4, 2025 Risk: low
Glucotrack, Inc. filed an 8-K on February 4, 2025, reporting an amendment to its Articles of Incorporation or Bylaws, a Regulation FD disclosure, and other even
Glucotrack, Inc. Files 8-K with Financials — Jan 30, 2025 Risk: low
Glucotrack, Inc. filed an 8-K on January 30, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as In
Glucotrack Director Departs, CEO Appointed to Board — Jan 29, 2025 Risk: medium
Glucotrack, Inc. announced on January 27, 2025, the departure of Director David J. Glickman. The company also elected Dr. Shlomo Ben-Haim as a new director and
Glucotrack, Inc. Files 8-K — Jan 21, 2025 Risk: low
Glucotrack, Inc. filed an 8-K on January 21, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain speci
Glucotrack Reports Unregistered Equity Sale — Jan 13, 2025 Risk: medium
Glucotrack, Inc. reported on January 6, 2025, an unregistered sale of equity securities. The filing does not disclose the specific number of shares sold or the
Glucotrack, Inc. Files 8-K for Regulatory Disclosure — Jan 8, 2025 Risk: low
Glucotrack, Inc. filed an 8-K on January 8, 2025, reporting events from January 7, 2025. The filing primarily concerns Regulation FD Disclosure and Financial St
Glucotrack, Inc. Files 8-K with Corporate Updates — Jan 7, 2025 Risk: low
Glucotrack, Inc. filed an 8-K on January 7, 2025, reporting events as of January 3, 2025. The filing indicates amendments to its Articles of Incorporation or By
Glucotrack Faces Delisting Concerns — Dec 31, 2024 Risk: high
Glucotrack, Inc. filed an 8-K on December 31, 2024, to report a notice of delisting or failure to satisfy a continued listing rule or standard. The company, for
Glucotrack, Inc. Files 8-K: Material Agreement & Exhibits — Dec 17, 2024 Risk: medium
On December 17, 2024, Glucotrack, Inc. filed an 8-K report. The filing indicates an entry into a material definitive agreement and includes financial statements
Glucotrack, Inc. Files 8-K — Dec 3, 2024 Risk: low
Glucotrack, Inc. filed an 8-K on December 3, 2024, reporting information under Regulation FD Disclosure and Financial Statements and Exhibits. The company, form
Glucotrack, Inc. Enters Material Definitive Agreement — Nov 18, 2024 Risk: medium
Glucotrack, Inc. filed an 8-K on November 18, 2024, reporting the entry into a material definitive agreement on November 12, 2024. The filing also includes fina
Glucotrack, Inc. Files 8-K with Disclosures — Nov 13, 2024 Risk: low
Glucotrack, Inc. filed an 8-K on November 13, 2024, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as I
Glucotrack, Inc. Files 8-K — Oct 22, 2024 Risk: low
Glucotrack, Inc. filed an 8-K on October 22, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain speci
Glucotrack, Inc. Files 8-K — Oct 1, 2024 Risk: low
Glucotrack, Inc. filed an 8-K on October 1, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specif
Glucotrack, Inc. Reports Shareholder Vote — Sep 26, 2024 Risk: low
Glucotrack, Inc. filed an 8-K on September 26, 2024, reporting on a matter submitted to a vote of its security holders on September 24, 2024. The filing does no
Glucotrack Reports Unregistered Equity Sale — Sep 10, 2024 Risk: medium
Glucotrack, Inc. reported on September 5, 2024, an unregistered sale of equity securities. The filing does not disclose specific details regarding the number of
Glucotrack CFO Departs, Interim Appointed — Sep 3, 2024 Risk: medium
Glucotrack, Inc. announced on August 27, 2024, the departure of its Chief Financial Officer, Mr. David J. Miller. The company has appointed Ms. Sarah E. Johnson
Glucotrack, Inc. Files 8-K with Corporate Updates — Aug 27, 2024 Risk: low
Glucotrack, Inc. filed an 8-K on August 27, 2024, to report on Regulation FD disclosures and financial statements. The filing details the company's principal ex
Glucotrack, Inc. Files 8-K for Disclosure and Exhibits — Aug 15, 2024 Risk: low
Glucotrack, Inc. filed an 8-K on August 15, 2024, to disclose information under Regulation FD and to file financial statements and exhibits. The filing does not

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX